Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2015 | Research article

Dural administration of inflammatory soup or Complete Freund’s Adjuvant induces activation and inflammatory response in the rat trigeminal ganglion

Authors: M. Lukács, KA Haanes, Zs. Majláth, J. Tajti, L. Vécsei, K. Warfvinge, L. Edvinsson

Published in: The Journal of Headache and Pain | Issue 1/2015

Abstract

Background

Migraine is a painful disorder with a huge impact on individual and public health. We hypothesize that migraine pain originates from a central mechanism that results secondarily in hypersensitivity in peripheral afferents associated with the cerebral and cranial blood vessels. It has previously been shown that application of inflammatory or algesic substances onto the dura mater or chemical stimulation of the dural receptive fields causes hypersensitivity to mechanical and thermal stimulation together with direct activation of the TG. We asked whether local inflammation of dura mater induces inflammatory activation in the trigeminal ganglion.

Methods

We performed topical administration of inflammatory soup (IS) or Complete Freund’s Adjuvant (CFA) onto an exposed area of the rat dura mater in vivo for 20 min. The window was closed and the rats were sacrificed after 4 h and up to 7 days. Myography was performed on middle meningeal arteries. The trigeminal ganglia were removed and processed for immunohistochemistry or Western blot.

Results

Both CFA and IS induced enhanced expression of pERK1/2, IL-1β and CGRP in the trigeminal ganglia. The pERK1/2 immunoreactivity was mainly seen in the satellite glial cells, while IL-1β reactivity was observed in the neuronal cytoplasm, close to the cell membrane, seemingly as sign of neuro-glial interaction. The CGRP expression in the neurons and nerve fibres was enhanced after the application of either inflammatory agent. Myography resulted in a strong vasoconstrictor response to IS, but not to CFA.

Conclusions

These results suggest that the application of IS or CFA onto the dura mater causes long-term activation of the TG and demonstrate the importance of the neuro-glial interaction in the activation of the trigeminovascular system.

Available only for authorised users

Stewart WF, Wood C, Reed ML, Roy J, Lipton RB (2008) Cumulative lifetime migraine incidence in women and men. Cephalalgia 28(11):1170–1178. doi:10.1111/j.1468-2982.2008.01666.x CrossRefPubMed

Bhaskar S, Saeidi K, Borhani P, Amiri H (2013) Recent progress in migraine pathophysiology: role of cortical spreading depression and magnetic resonance imaging. Eur J Neurosci 38(11):3540–3551. doi:10.1111/ejn.12368 CrossRefPubMed

Moskowitz MA (1991) The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 41(2 (Pt 1)):182–186. doi:10.1212/WNL.41.2_Part_1.182 CrossRefPubMed

Strassman AM, Levy D (2006) Response properties of dural nociceptors in relation to headache. J Neurophysiol 95(3):1298–1306. doi:10.1152/jn.01293.2005 CrossRefPubMed

Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM (2007) Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 130(1–2):166–176. doi:10.1016/j.pain.2007.03.012 CrossRefPubMedCentralPubMed

Kuris A, Xu CB, Zhou MF, Tajti J, Uddman R, Edvinsson L (2007) Enhanced expression of CGRP in rat trigeminal ganglion neurons during cell and organ culture. Brain Res 1173:6–13. doi:10.1016/j.brainres.2007.07.073 CrossRefPubMed

Tajti J, Kuris A, Vecsei L, Xu CB, Edvinsson L (2011) Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2. Cephalalgia 31(1):95–105. doi:10.1177/0333102410382796 CrossRefPubMed

Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79(2):964–982PubMed

Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384(6609):560–564. doi:10.1038/384560a0 CrossRefPubMed

10.

Hoffmann J, Wecker S, Neeb L, Dirnagl U, Reuter U (2012) Primary trigeminal afferents are themain source for stimulus-induced CGRP release into jugular vein blood and CSF. Cephalalgia 32(9):659–667. doi:10.1177/0333102412447701 CrossRefPubMed

11.

Burstein R, Jakubowski M (2004) Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 55(1):27–36. doi:10.1002/ana.10785 CrossRefPubMed

12.

Zhang X, Kainz V, Zhao J, Strassman AM, Levy D (2013) Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors. Ann Neurol 73(6):741–750. doi:10.1002/ana.23873 CrossRefPubMedCentralPubMed

13.

Iwashita T, Shimizu T, Shibata M, Toriumi H, Ebine T, Funakubo M, Suzuki N (2013) Activation of extracellular signal-regulated kinase in the trigeminal ganglion following both treatment of the dura mater with capsaicin and cortical spreading depression. Neurosci Res 77(1–2):110–119. doi:10.1016/j.neures.2013.08.001 CrossRefPubMed

14.

Ren K, Torres R (2009) Role of interleukin-1beta during pain and inflammation. Brain Res Rev 60(1):57–64. doi:10.1016/j.brainresrev.2008.12.020 CrossRefPubMedCentralPubMed

15.

Watkins LR, Maier SF, Goehler LE (1995) Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63(3):289–302. doi:10.1016/0304-3959(95)00186-7 CrossRefPubMed

16.

Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10(11):1361–1368. doi:10.1038/nn1992 CrossRefPubMed

17.

Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 372(9656):2115–2123. doi:10.1016/S0140-6736(08)61626-8 CrossRefPubMed

18.

Edvinsson L, Chan KY, Eftekhari S, Nilsson E, de Vries R, Saveland H, Dirven CM, Danser AH, MaassenVanDenBrink A (2010) Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia 30(10):1233–1240. doi:10.1177/0333102410362122 CrossRefPubMed

19.

Durham PL, Russo AF (1999) Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci 19(9):3423–3429PubMed

20.

Haanes KA, Edvinsson L (2014) Expression and characterization of purinergic receptors in rat middle meningeal artery-potential role in migraine. PLoS One 9(9), e108782. doi:10.1371/journal.pone.0108782 CrossRefPubMedCentralPubMed

21.

Gao YJ, Ji RR (2009) c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? Open Pain J 2:11–17. doi:10.2174/1876386300902010011 CrossRefPubMedCentralPubMed

22.

Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ (2001) Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410(6827):471–475. doi:10.1038/35068566 CrossRefPubMed

23.

Ashina M, Tfelt-Hansen P, Dalgaard P, Olesen J (2011) Lack of correlation between vasodilatation and pharmacologically induced immediate headache in healthy subjects. Cephalalgia 31(6):683–690. doi:10.1177/0333102410394672 CrossRefPubMed

24.

Wienecke T, Olesen J, Ashina M (2011) Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D(2) (PGD(2)). Cephalalgia 31(1):65–76. doi:10.1177/0333102410373156 CrossRefPubMed

25.

Lang E, Novak A, Reeh PW, Handwerker HO (1990) Chemosensitivity of fine afferents from rat skin in vitro. J Neurophysiol 63(4):887–901PubMed

26.

Hossaini M, Duraku LS, Kohli SK, Jongen JL, Holstege JC (2014) Spinal distribution of c-Fos activated neurons expressing enkephalin in acute and chronic pain models. Brain Res 1543:83–92. doi:10.1016/j.brainres.2013.10.044 CrossRefPubMed

27.

Hirsch S, Corradini L, Just S, Arndt K, Doods H (2013) The CGRP receptor antagonist BIBN4096BS peripherally alleviates inflammatory pain in rats. Pain 154(5):700–707. doi:10.1016/j.pain.2013.01.002 CrossRefPubMed

28.

O'Connor TP, van der Kooy D (1986) Pattern of intracranial and extracranial projections of trigeminal ganglion cells. J Neurosci 6(8):2200–2207PubMed

29.

Olesen J, Burstein R, Ashina M, Tfelt-Hansen P (2009) Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 8(7):679–690. doi:10.1016/S1474-4422(09)70090-0 CrossRefPubMed

30.

Jensen K (1993) Extracranial blood flow, pain and tenderness in migraine. Clinical and experimental studies. Acta Neurol Scand Suppl 147:1–27CrossRefPubMed

31.

Freeman SE, Patil VV, Durham PL (2008) Nitric oxide-proton stimulation of trigeminal ganglion neurons increases mitogen-activated protein kinase and phosphatase expression in neurons and satellite glial cells. Neuroscience 157(3):542–555. doi:10.1016/j.neuroscience.2008.09.035 CrossRefPubMedCentralPubMed

32.

Ji RR, Baba H, Brenner GJ, Woolf CJ (1999) Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 2(12):1114–1119. doi:10.1038/16040 CrossRefPubMed

33.

Dublin P, Hanani M (2007) Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain. Brain Behav Immun 21(5):592–598. doi:10.1016/j.bbi.2006.11.011 CrossRefPubMed

34.

Ruohonen S, Khademi M, Jagodic M, Taskinen HS, Olsson T, Roytta M (2005) Cytokine responses during chronic denervation. J Neuroinflammation 2:26. doi:10.1186/1742-2094-2-26 CrossRefPubMedCentralPubMed

35.

Copray JC, Mantingh I, Brouwer N, Biber K, Kust BM, Liem RS, Huitinga I, Tilders FJ, Van Dam AM, Boddeke HW (2001) Expression of interleukin-1 beta in rat dorsal root ganglia. J Neuroimmunol 118(2):203–211CrossRefPubMed

36.

Capuano A, De Corato A, Lisi L, Tringali G, Navarra P, Dello Russo C (2009) Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 5:43. doi:10.1186/1744-8069-5-43 CrossRefPubMedCentralPubMed

37.

Opree A, Kress M (2000) Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 20(16):6289–6293PubMed

38.

Durham PL (2006) Calcitonin gene-related peptide (CGRP) and migraine. Headache 46(Suppl 1):S3–S8. doi:10.1111/j.1526-4610.2006.00483.x CrossRefPubMedCentralPubMed

39.

Lei L, Yuan X, Wang S, Zhang F, Han Y, Ning Q, Luo G, Lu S (2012) Mitogen-activated protein kinase pathways are involved in the upregulation of calcitonin gene-related peptide of rat trigeminal ganglion after organ culture. J Mol Neurosci 48(1):53–65. doi:10.1007/s12031-012-9772-y CrossRefPubMed

40.

Paul L, Durham PL (2003) Stimulation of the Calcitonin Gene-Related Peptide Enhancer by Mitogen-Activated Protein Kinases and Repression by an Antimigraine Drug in Trigeminal Ganglia. Neurons J Neurosci 23(3):807–815

41.

Edvinsson L (2015) CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol. doi:10.1111/bcp.12618 PubMed

42.

Link AS, Kuris A, Edvinsson L (2008) Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. J Headache Pain 9(1):5–12. doi:10.1007/s10194-008-0011-4 CrossRefPubMedCentralPubMed

43.

Hostetler ED, Joshi AD, Sanabria-Bohorquez S, Fan H, Zeng Z, Purcell M, Gantert L, Riffel K, Williams M, O'Malley S, Miller P, Selnick HG, Gallicchio SN, Bell IM, Salvatore CA, Kane SA, Li CC, Hargreaves RJ, de Groot T, Bormans G, Van Hecken A, Derdelinckx I, de Hoon J, Reynders T, Declercq R, De Lepeleire I, Kennedy WP, Blanchard R, Marcantonio EE, Sur C et al (2013) In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232. J Pharmacol Exp Ther 347(2):478–486. doi:10.1124/jpet.113.206458 CrossRefPubMed

44.

Amin FM, Asghar MS, Hougaard A, Hansen AE, Larsen VA, de Koning PJ, Larsson HB, Olesen J, Ashina M (2013) Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol 12(5):454–461. doi:10.1016/S1474-4422(13)70067-X CrossRefPubMed

45.

Grande G, Labruijere S, Haanes KA, MaassenVanDenBrink A, Edvinsson L (2014) Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds. J Headache Pain 15:22. doi:10.1186/1129-2377-15-22 CrossRefPubMedCentralPubMed

Title: Dural administration of inflammatory soup or Complete Freund’s Adjuvant induces activation and inflammatory response in the rat trigeminal ganglion
Authors: M. Lukács
KA Haanes
Zs. Majláth
J. Tajti
L. Vécsei
K. Warfvinge
L. Edvinsson
Publication date: 01-12-2015
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2015
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-015-0564-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Dural administration of inflammatory soup or Complete Freund’s Adjuvant induces activation and inflammatory response in the rat trigeminal ganglion

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Acknowledgements to Referees

Photo-, osmo- and phonophobia in the premonitory phase of migraine: mistaking symptoms for triggers?

Headache, migraine and risk of brain tumors in women: prospective cohort study

Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience

Cluster headache: a quasi-rare disorder needing a reappraisal

OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients